Peter Dull

Peter is Deputy Director for Integrated Clinical Vaccine Development within the Global Health Division at the Bill and Melinda Gates Foundation. In this role he provides technical and strategic guidance on clinical development to the foundation’s program strategy teams and external partners. In addition, he leads the foundation’s vaccine development activities for HPV vaccines, including efforts on new product development and reduced dose schedules. He joined the foundation after 10 years at Novartis Vaccines where he was the Clinical Franchise Head for Meningitis and Sepsis Vaccines, leading the clinical development global licensure of MenACWY-CRM (Menveo) and 4CMenB (Bexsero). During the Covid-19 pandemic, in addition to providing direct support for grantees developing new COVID-19 vaccines, he co-led with CEPI partners the COVAX Clinical SWAT team providing product-agnostic support to developers to accelerate vaccine licensure and WHO pre-qualification with an LMIC focus. Prior to joining Novartis, he was an Epidemic Intelligence Service officer in the Meningitis and Special Pathogens Branch at the US Centers for Disease Control and completed subspecialty training in infectious diseases at Emory University.